Grantham, Mayo, Van Otterloo & Co (GMO)’s Meridian Bioscience Inc VIVO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-127,001
| Closed | -$4.22M | – | 788 |
|
2022
Q4 | $4.22M | Buy |
127,001
+116,701
| +1,133% | +$3.88M | 0.02% | 360 |
|
2022
Q3 | $325K | Sell |
10,300
-11,300
| -52% | -$357K | ﹤0.01% | 619 |
|
2022
Q2 | $657K | Buy |
+21,600
| New | +$657K | ﹤0.01% | 578 |
|
2021
Q4 | – | Sell |
-42,117
| Closed | -$810K | – | 758 |
|
2021
Q3 | $810K | Sell |
42,117
-30,700
| -42% | -$590K | ﹤0.01% | 551 |
|
2021
Q2 | $1.62M | Sell |
72,817
-29,400
| -29% | -$652K | 0.01% | 486 |
|
2021
Q1 | $2.68M | Sell |
102,217
-158,883
| -61% | -$4.17M | 0.01% | 431 |
|
2020
Q4 | $4.88M | Sell |
261,100
-154,600
| -37% | -$2.89M | 0.03% | 292 |
|
2020
Q3 | $7.06M | Buy |
415,700
+159,200
| +62% | +$2.7M | 0.05% | 193 |
|
2020
Q2 | $5.97M | Buy |
256,500
+211,500
| +470% | +$4.93M | 0.04% | 225 |
|
2020
Q1 | $378K | Buy |
+45,000
| New | +$378K | ﹤0.01% | 634 |
|